Emergency hospitalizations for adverse drug events in China: Clinical pharmacists' approach to assessment and categorization
- PMID: 33630347
- DOI: 10.1002/pds.5215
Emergency hospitalizations for adverse drug events in China: Clinical pharmacists' approach to assessment and categorization
Abstract
Purpose: Little is known about emergency hospitalizations owing to adverse drug events (ADEs) in Chinese populations. The aim of this study was to identify the types and characteristics of ADEs as well as estimate the length of hospital stay and ADE-related costs in a hospital emergency setting in China.
Methods: This prospective study was conducted in the emergency department of our hospital from April 1, 2017 to December 31, 2019. ADEs of patients admitted to the emergency department were collected by a clinical pharmacist during daily pharmacy rounds.
Results: Of 4020 cases admitted to the emergency department, 198 emergency ADE-related hospitalizations (4.93%) were noted, which were classified into certain (n = 0, 0%), probable (n = 122, 61.6%), and possible (n = 76, 38.4%). The ADE was serious in 93.9% of the 198 cases. Ten cases were fatal, and two cases were life-threatening. More than 80% of the emergency ADE-related hospitalization cases were of patients over 60 years. The pharmacological agents implicated in the hospitalizations were oral antiplatelet agents (20.7%), oral hypoglycemic agents (16.7%), insulin (11.1%), and antihypertensive agents (9.1%). The average length of ADE-related hospital stay was 10 (7.0-14.0) days. ADE-related costs ranged from $1684.68 to $4531.35 for each hospitalization. The length of ADE-related hospital stay and associated costs were statistically significant. Most ADEs (n = 146, 73.7%) were preventable.
Conclusions: Most emergency ADE-related hospitalizations in older adults resulted from lack of medication monitoring or inappropriate medication. Improved management of medicines by clinical pharmacists has the potential to reduce ADE-related hospitalizations in older adults in China.
Keywords: adverse drug events; clinical pharmacist; elderly patients; pharmaceutical care.
© 2021 John Wiley & Sons Ltd.
Similar articles
-
Hospital admissions caused by adverse drug events: an Australian prospective study.Aust Health Rev. 2014 Feb;38(1):51-7. doi: 10.1071/AH12027. Aust Health Rev. 2014. PMID: 24351707
-
Adverse Drug Events Detected by Clinical Pharmacists in an Emergency Department: A Prospective Monocentric Observational Study.J Patient Saf. 2021 Dec 1;17(8):e1040-e1049. doi: 10.1097/PTS.0000000000000679. J Patient Saf. 2021. PMID: 32175969
-
The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).BMC Health Serv Res. 2011 May 25;11:124. doi: 10.1186/1472-6963-11-124. BMC Health Serv Res. 2011. PMID: 21612624 Free PMC article.
-
Adverse drug events as a cause of hospitalization in older adults.Drug Saf. 2012 Jan;35 Suppl 1:29-45. doi: 10.1007/BF03319101. Drug Saf. 2012. PMID: 23446784 Review.
-
Interventions to Reduce Adverse Drug Event-Related Outcomes in Older Adults: A Systematic Review and Meta-analysis.Drugs Aging. 2020 Feb;37(2):91-98. doi: 10.1007/s40266-019-00738-w. Drugs Aging. 2020. PMID: 31919801
Cited by
-
Prioritisation of Adverse Drug Events Leading to Hospital Admission and Occurring during Hospitalisation: A RAND Survey.J Clin Med. 2022 Jul 22;11(15):4254. doi: 10.3390/jcm11154254. J Clin Med. 2022. PMID: 35893345 Free PMC article.
-
Which Adverse Events and Which Drugs Are Implicated in Drug-Related Hospital Admissions? A Systematic Review and Meta-Analysis.J Clin Med. 2023 Feb 7;12(4):1320. doi: 10.3390/jcm12041320. J Clin Med. 2023. PMID: 36835854 Free PMC article.
-
Adverse drug events in Chinese elder inpatients: a retrospective review for evaluating the efficiency of the Global Trigger Tool.Front Med (Lausanne). 2023 Sep 28;10:1232334. doi: 10.3389/fmed.2023.1232334. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37841014 Free PMC article.
-
Drug-microbiota interactions: an emerging priority for precision medicine.Signal Transduct Target Ther. 2023 Oct 9;8(1):386. doi: 10.1038/s41392-023-01619-w. Signal Transduct Target Ther. 2023. PMID: 37806986 Free PMC article. Review.
References
REFERENCES
-
- Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301-306.
-
- Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377-384.
-
- Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993. Lancet. 1998;351:643-644.
-
- Fanikos J, Cina JL, Baroletti S, Fiumara K, Matta L, Goldhaber SZ. Adverse drug events in hospitalized cardiac patients. Am J Cardiol. 2007;100:1465-1469.
-
- Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277:307.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous